Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (3)

2024

  1. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666

2012

  1. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study

    Multidisciplinary Respiratory Medicine, Vol. 7, Núm. 5

2010

  1. Factors associated with asthma control in primary care patients: The CHAS study

    Archivos de Bronconeumologia, Vol. 46, Núm. 7, pp. 358-363